Atlas Trials

Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects

Clinical trial NCT03279302 · COMPLETED

Trial details

NCT number
NCT03279302
Sponsor
Zealand Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2017-09-04
Primary completion
2017-12-18
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.